<code id='BB7DFAEA0A'></code><style id='BB7DFAEA0A'></style>
    • <acronym id='BB7DFAEA0A'></acronym>
      <center id='BB7DFAEA0A'><center id='BB7DFAEA0A'><tfoot id='BB7DFAEA0A'></tfoot></center><abbr id='BB7DFAEA0A'><dir id='BB7DFAEA0A'><tfoot id='BB7DFAEA0A'></tfoot><noframes id='BB7DFAEA0A'>

    • <optgroup id='BB7DFAEA0A'><strike id='BB7DFAEA0A'><sup id='BB7DFAEA0A'></sup></strike><code id='BB7DFAEA0A'></code></optgroup>
        1. <b id='BB7DFAEA0A'><label id='BB7DFAEA0A'><select id='BB7DFAEA0A'><dt id='BB7DFAEA0A'><span id='BB7DFAEA0A'></span></dt></select></label></b><u id='BB7DFAEA0A'></u>
          <i id='BB7DFAEA0A'><strike id='BB7DFAEA0A'><tt id='BB7DFAEA0A'><pre id='BB7DFAEA0A'></pre></tt></strike></i>

          entertainment

          entertainment

          author:entertainment    Page View:18874
          Tome cofounders Jonathan Gootenberg, left, and Omar Abudayyeh, a scientific team that's trying to reinvent gene editing for a new era of biotech innovation.
          Suzanne Kreiter/Globe staff

          WATERTOWN — Their brainstorming began in an MIT class in 2010 when the eager undergrads shot each other emails about how to solve a bioengineering equation. It has continued for 14 years over sushi dinners, between Marvel movies, and during rowing-machine workouts.

          Together, Omar Abudayyeh, 33, and Jonathan Gootenberg, 32, have probed the mysteries of genomic editing and COVID detection. They co-published 10 scientific papers, helped launch two medical-diagnostic companies, and cofounded a Watertown startup, Tome Biosciences, that reengineers genes and cells to cure diseases. They also run the Abudayyeh-Gootenberg Lab at Harvard.

          advertisement

          Gootenberg and Abudayyeh are an unusual pair, two scientists — a Jewish American and a Palestinian American — who prefer working together in a field that often draws solitary researchers and rewards individual achievement.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more
          Covid overtakes 1918 Spanish flu as deadliest disease in U.S. history
          Covid overtakes 1918 Spanish flu as deadliest disease in U.S. history

          VolunteernursesfromtheAmericanRedCrosstendtoinfluenzapatientsintheOaklandMunicipalAuditorium,usedasa

          read more
          Medical records are filled with copy
          Medical records are filled with copy

          AdobeIrecentlytookcareofapatientwhosemedicalrecordsincludedmultiplenotesaboutherpastopen-heartsurger

          read more

          Change Healthcare cyberattack shows risk of industry consolidation

          AdobeChangeHealthcare’srecentcyberattackhashospitals,doctors’offices,andpharmaciesacrossthecountryre